Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2-neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment

1 Citations

Journal

Citations (1)*help

See more

Details 詳細情報について

  • CRID
    1571135651223130112
  • NII Article ID
    10027626276
  • Data Source
    • CiNii Articles

Report a problem

Back to top